EMPHYSEMA

This study follows patients who receive the FDA-approved Spiration Valve System to treat severe emphysema. Researchers will track 150 participants for three years to monitor the long-term safety and effectiveness of these lung valves. The study aims to gather real-world data on h…

This study is testing whether a new, specialized clinic can help people with COPD who are also losing muscle mass. The clinic uses a team of different health professionals to diagnose and treat this muscle loss. Researchers will compare patients in this new clinic to those receiv…

This study aims to evaluate the long-term safety and effectiveness of an investigational drug called SAR447537 (INBRX-101) for adults with emphysema caused by Alpha-1 antitrypsin deficiency. The trial will follow 185 participants who continue receiving the treatment to monitor si…

This study is testing a new medical device called the IAB 50 Flex, which is a small, flexible implant placed in the airways. It aims to help adults with severe emphysema or COPD breathe more easily by supporting damaged lung tissue. The trial will enroll 20 participants at two ho…

This study is testing a small, permanent implant designed to prop open airways in the lungs of people with severe COPD and emphysema. The goal is to see if this device can safely release trapped air and help patients breathe easier when standard medications aren't enough. About 2…

This study is creating a large research registry of people with emphysema and COPD. It aims to collect health information, breathing test results, and genetic samples from up to 3,000 participants. The goal is to help scientists better understand these lung diseases and identify …